Mirae Asset Global Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Mirae Asset Global Investments’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,735	Closed	-$718K	–	781
2017 Q4	$718K	Buy	+14,735	New	+$745K	0.01%	531
2016 Q2	–	Sell	-71,841	Closed	-$1.47M	–	546
2016 Q1	$1.47M	Buy	71,841 +35,192	+96%	+$1.12M	0.04%	260
2015 Q4	$1.89M	Buy	36,649 +6,322	+21%	+$307K	0.06%	230
2015 Q3	$1.29M	Sell	30,327 -2,800	-8%	-$135K	0.05%	264
2015 Q2	$1.51M	Buy	33,127 +20,575	+164%	+$828K	0.05%	254
2015 Q1	$476K	Buy	+12,552	New	+$431K	0.02%	373

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Mirae Asset Global Investments's PTLA Position: Q1 2018 in Review

Mirae Asset Global Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2018, closing a stake of 14,735 shares — an estimated $718K sold.

Mirae Asset Global Investments first reported a position in PTLA in Q1 2015 and held it in 6 quarters. The position peaked at $1.89M in Q4 2015. 180 funds tracked by Wall St. Rank hold PTLA as of Q1 2018.

Mirae Asset Global Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Mirae Asset Global Investments sold 14,735 Portola Pharmaceuticals, Inc. shares in Q1 2018, an estimated $718K.
Mirae Asset Global Investments first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
Mirae Asset Global Investments's Portola Pharmaceuticals, Inc. position peaked at $1.89M in Q4 2015.
180 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2018.

Based on Mirae Asset Global Investments's 13F filing for Q1 2018, filed 10 May 2018.